Public Market Listing
688321SSE
Live quotes, historical charts, and market capitalization for Chipscreen Biosciences are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(4 total)
4Total Assets
0Approved
2Phase 3 / Filed
2Phase 1–2 / Early
3Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | HDACSmall molecule | Non-Small Cell Lung Cancer | |
Chiglitazar(Bilessglu) | Phase 3 | PPAR (pan-agonist)Small molecule | Type 2 Diabetes |
| Phase 1/2 | TYK2Small molecule | Psoriasis | |
| Phase 1 | PRMT5 (protein arginine methyltransferase 5), MTA-cooperativeSmall molecule | Non-Small Cell Lung Cancer |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.